Asunto(s)
Eritema/diagnóstico , Dermatosis de la Pierna/diagnóstico , Prurito/diagnóstico , Enfermedades Cutáneas Genéticas/diagnóstico , Anciano de 80 o más Años , Eritema/complicaciones , Eritema/patología , Femenino , Humanos , Dermatosis de la Pierna/patología , Prurito/complicaciones , Prurito/patología , Enfermedades Cutáneas Genéticas/complicaciones , Enfermedades Cutáneas Genéticas/patología , TorsoAsunto(s)
Enfermedades de la Uña/terapia , Penfigoide Ampolloso , Pénfigo , Psoriasis/terapia , HumanosRESUMEN
The risk of melanoma in organ transplant recipients (OTR) is increased compared with the general population. This retrospective study registered all cases of post-transplant melanoma in kidney, heart, lung, and liver transplant recipients followed in our specialized post-transplant Dermatology Clinic since 1991. The yearly prevalence of melanoma and skin carcinoma between 2000 and 2015 was computed and compared in this population. Based on another cohort of kidney transplant recipients grafted since 2005, adjusted age- and sex-standardized incidence ratio (SIR) was calculated using a renal transplantation registry. In our overall OTR cohort, between 1991 and 2000, five melanomas occurred in 1800 OTRs (0.28%), whereas between 1991 and 2015, 53 melanomas were diagnosed in 49 of 4510 OTR (1.09%), representing a 3.9-fold increase in prevalence after 2000. Remarkably, the prevalence of nonmelanoma skin cancers remained unchanged over this period. Two deaths related to melanoma were recorded with an overall follow-up of 62 months. In our cohort of 1102 renal transplant recipients, the SIR of melanoma was 4.52. Our data suggest that contrasting with nonmelanoma skin cancer, the risk of post-transplant melanoma has considerably increased over the last decade.
Asunto(s)
Melanoma/mortalidad , Trasplante de Órganos , Complicaciones Posoperatorias/mortalidad , Neoplasias Cutáneas/mortalidad , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Femenino , Francia/epidemiología , Humanos , Terapia de Inmunosupresión/efectos adversos , Incidencia , Masculino , Melanoma/etiología , Melanoma/terapia , Persona de Mediana Edad , Prevalencia , Estudios Retrospectivos , Neoplasias Cutáneas/etiología , Neoplasias Cutáneas/terapia , Adulto JovenRESUMEN
Necrotizing Infundibular Crystalline Folliculitis (NICF) is rare entity of unknown pathogenesis presenting as follicular crystalline papules arising in seborrheic areas. We report 2 cases of NICF in patients under targeted therapy for metastatic adenocarcinoma. In one case, the lesions reappeared cyclically every 3 weeks after each injection and in the other case, lesions persisted until disruption of the continuous oral therapy. Punch-biopsies demonstrated folliculitis with a plugging crystalline material associated with either bacteria or yeast. These are the first descriptions of drug-induced NICF.
